Estimations des analystes de Wall Street pour Adicet Bio, Inc. (ACET): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 9 |
| Conserver | 3 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 12 |
| Note moyenne (1-5) | 0.75 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-04 | $-1.56 | ||
| 2026-08-05 | $-1.99 | $-1.69 | -17.8% |
| 2026-05-13 | $-1.88 | $-2.93 | +35.8% |
| 2026-03-12 | $-2.94 | $-2.99 | +1.6% |
| 2025-11-05 | $-4.64 | $-4.16 | -11.5% |
| 2025-08-07 | $-5.44 | $-4.86 | -11.9% |
| 2025-05-06 | $-4.96 | $-5.31 | +6.5% |
| 2025-03-06 | $-5.12 | $-0.36 | -1322.2% |
Ratios de valorisation
| Prix / Valeur comptable | 0.82 |
| EV / EBITDA | -0.77 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $547.0M | $558.5M | $8.2M | $995000 | $17.9M | $9.7M | $25.0M | 0 | 0 | 0 |
| Coût des Ventes | $411.5M | $5000 | $80000 | 0 | 0 | 0 | 0 | 0 | 0 | $6.4M |
| Marge Brute | $135.4M | $558.5M | $8.1M | $995000 | $17.9M | $9.7M | $25.0M | 0 | 0 | -$6.4M |
| R&D | $5.9M | $16.8M | $14.7M | $23.7M | $34.3M | $48.9M | $71.2M | $106.0M | $99.3M | $99.1M |
| Frais Généraux | $1000 | $2.0M | $8.4M | $8.7M | $22.8M | $22.2M | $26.3M | $26.5M | $28.3M | $23.0M |
| Charges Opérationnelles | $1000 | $18.9M | $23.1M | $32.4M | $57.1M | $71.2M | $97.5M | $152.0M | $127.6M | $115.7M |
| Résultat Opérationnel | -$1000 | -$18.9M | -$15.0M | -$31.4M | -$39.2M | -$61.4M | -$72.6M | -$152.0M | -$127.6M | -$122.1M |
| EBITDA | -$1000 | -$33.8M | -$13.7M | -$26.9M | -$37.4M | -$60.4M | -$64.7M | -$136.5M | -$110.7M | -$110.4M |
| Charges d'Intérêt | $4.0M | $7.0M | 0 | 0 | $134000 | $176000 | $80000 | $25000 | $4000 | $36000 |
| Résultat Avant Impôts | -$1000 | -$33.8M | -$9.9M | -$28.1M | -$39.5M | -$62.1M | -$69.8M | -$142.7M | -$117.1M | -$116.8M |
| Impôts | 0 | 0 | -$589000 | $19000 | -$2.8M | -$125000 | 0 | 0 | 0 | 0 |
| Résultat Net | -$1000 | -$33.8M | -$9.3M | -$28.1M | -$36.7M | -$62.0M | -$69.8M | -$142.7M | -$117.1M | -$116.8M |
| BPA | $-0.00 | $-20.16 | $-4.96 | $-24.32 | $-80.16 | $-32.00 | $-27.20 | $-52.96 | $-21.28 | $-16.95 |
| BPA Dilué | $-0.00 | $-20.00 | $-4.96 | $-24.32 | $-80.16 | $-32.00 | $-27.20 | $-52.96 | $-21.28 | $-16.95 |
| Actions en Circulation (Diluées) | $1.8M | $1.7M | $1.9M | $1.2M | $457499 | $1.9M | $2.6M | $2.7M | $5.5M | $6.9M |
Prix
| Prix | $9.05 |
| Capitalisation | $85M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ACRV · ADAG · CRVO · GANX · HOWL · IMUX · IOBT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ACET: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions